Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

April 30, 2014 by Alan Khadavi

AAAAI Releases Second Choosing Wisely List

The AAAAI released their second choose wisely list about specific tests and procedures allergists do.  Here are their 5 recommendations.

Filed Under: Blog

April 18, 2014 by Alan Khadavi

Ragweed Tablet approved

The FDA recently approved Merck’s ragweed tablet, RAGWITEK.  This follows on the heels of recently approved grass tablets, GRASTEK and ORALAIR.

Filed Under: Blog

April 18, 2014 by Alan Khadavi

Miley Cyrus admitted to hospital for Allergic Reaction

Pop sensation Miley Cyrus has recently been hospitalized for an allergic reaction to antibiotics.

Filed Under: Blog, Headlines

March 21, 2014 by Alan Khadavi

FDA approves Xolair for Chronic Urticaria

Today Novartis announced that Omalizumab which has been used for Allergic Asthma, has been given an indication for chronic hives.

Filed Under: Blog

March 6, 2014 by Alan Khadavi

Xolair (Omalizumab) for Chronic Urticaria

More and more studies seem to come out showing the effects of Xolair for the treatment of chronic idiopathic urticaria (CIU).

Filed Under: Blog

February 27, 2014 by Alan Khadavi

Itching is not all Histamine

Itching is predominant feature in many inflammatory and tumor related skin diseases.

Filed Under: Blog

February 26, 2014 by Alan Khadavi

Primatene Mist not likely to get FDA approval

The FDA met yesterday to discuss whether or not to approve Primatene Mist for asthma.

Filed Under: Blog

February 18, 2014 by Alan Khadavi

Gluten Free in the news

A recent article in the New York Times looked at the explosion of gluten free products hitting the market.

Filed Under: Blog

February 17, 2014 by Alan Khadavi

Olympian quits over Allergies

Norways’ Aksel Lund Svindal, who won 3 medals in skiing at the last Olympics, decided to withdraw from his last event in Sochi, Russia because of his allergies.

Filed Under: Blog

February 14, 2014 by Alan Khadavi

Nasocort is now Over the Counter (OTC)

Recently the FDA approved Nasocort (triamcinolone) nasal spray for OTC use, without a prescription.  This is a nasal steroid spray used to treat seasonal and perennial allergies.

Filed Under: Blog

  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page